...
首页> 外文期刊>Prescrire international >Direct-to-consumer advertising: the European Commission's plan
【24h】

Direct-to-consumer advertising: the European Commission's plan

机译:直接面向消费者的广告:欧盟委员会的计划

获取原文
获取原文并翻译 | 示例
           

摘要

Freedom of disinformation.Once again, the European Commission is pursuing its plans to allow pharmaceutical companies to advertise prescription drugs directly to the public (1,2).Obsession. In 2002, European deputies overwhelmingly rejected plans by the European Commission's Enterprise Directorate to legalise direct-to-consumer advertising of prescription drugs (1). The Commission simply obtained a mandate to make proposals intended to improve public access to high-quality health information. Yet, in 2007, the Commission again proposed to allow direct-to-consumer advertising (1).The European Commission has virtually ignored criticisms made during the public consultation on its proposal. It is now citing patients' right to information in support of its draft Directive (2). Drug companies insist they are not seeking to lift the ban on direct-to-public advertising of prescription drugs, but claim it is their "duty" to convey information on their products to the public that only they possess (a).
机译:虚假信息自由:欧盟委员会再次执行其计划,允许制药公司直接向公众宣传处方药(1,2)。 2002年,欧洲代表以压倒性多数否决了欧盟委员会企业局关于将直接面向消费者的处方药广告合法化的计划(1)。委员会仅获得一项授权,就提出旨在改善公众对高质量卫生信息的获取的提案。然而,在2007年,欧盟委员会再次提议允许直接面向消费者的广告(1)。欧盟委员会实际上无视公众咨询期间对其提议的批评。它现在引用患者的知情权以支持其指令草案(2)。制药公司坚称,他们并未试图取消禁止直接向公众宣传处方药的禁令,但声称将只有其拥有的产品信息向公众传达是他们的“职责”。

著录项

  • 来源
    《Prescrire international》 |2010年第107期|共1页
  • 作者

  • 作者单位
  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号